Impact Metrics BioRegió 2015 - Biocat

1. BIOREGION OF CATALONIA
www.biocat.cat
IMPACT
METRICS

2. THEBIOREGIONOFCATALONIA
ARESEARCHANDINNOVATIONHUBINSOUTHERNEUROPECatalonia is the most dynamic bioregion in Spain. The BioRegion of Catalonia brings together 560 companies as
well as 56 research centers, 17 university hospitals and 11 universities offering studies in the life sciences. 16
science and technology parks with activity in the life sciences, more than 100 scientific platforms and large
research facilities like the Alba-Cells Synchrotron, the Barcelona Supercomputing Center (BSC) and the
National Center for Genomic Analysis (CNAG) make Catalonia and its capital, Barcelona, an outstanding
research and innovation hub in southern Europe.
BIOCAT,DRIVINGTHEBIOCLUSTERBiocat is the organization that coordinates and promotes the life sciences sector in Catalonia. Biocat’s mission is
to support and dynamize all the stakeholders in this area to boost research, innovation and companies’ growth in
order to make the life sciences a driving force for the country’s economy and contribute to the wellbeing of society
as a whole. Created in 2006 at the behest of the Government of Catalonia and the Barcelona City Council, Biocat
is a foundation that brings together representatives from all areas of the biotechnology, biomedicine and medical
technology sector: administrations, universities, research centers, companies and support bodies.

3. UNIVERSITIES(OUTOF12)
OFFERINGSTUDIESIN
LIFESCIENCES
11
LARGERESEARCH
FACILITIES
2
UNIVERSITYHOSPITALS17
RESEARCHINSTITUTES
(OUTOF66)
56
TECHNOLOGICAL
CENTERS
12
SCIENCE&
TECHNOLOGYPARKS
16
64 MEDTECH
39 PHARMA
124 SUPPLIER
&ENGINEERING
25 INVESTORS
PROFESSIONAL
SERVICESAND
CONSULTING
111
BIOTECH197
11
2
17
56
12
16
64
39
124
25
111
197
114RESEARCH
ORGANIZATIONS
560COMPANIES
Source: Biocat Directory (December 2014)
AWIDEECOSYSTEMWHERESCIENCEANDBUSINESSMEET

4. Sources: Biocat Directory (Dec. 2014), Catalan Union of Hospitals, Government of Catalonia and SABI
EMPLOYMENTANDRESOURCES
COMPANIES RESEARCHCENTERS HOSPITALS
3.500
7.200WORKERS
+90.000WORKERS(PUBLIC PROVIDERS)
4.500RESEARCHERS RESEARCHERS
INBIOMEDICINE
35.000
PHARMA
13.800
BIOTECH
8.500 OTHERS
6.300
MEDTECH
6.400
WORKERS
COMPANIESHADREVENUES
OVER11.000M€AND
CONTRIBUTEDWITH6%
TOTHEGDPINCATALONIA
IN10YEARS,HUMANRESOURCESINR&DHAVE
INCREASED50%ANDTHERESEARCHCOMMUNITY60%

5. Source: FECYT, Farmaindustria, INE (2013)
INVESTMENTINCATALONIAINR&D
€345M
PHARMA
INDUSTRY
€147M
BIOTECH
COMPANIES
€ 681M
UNIVERSITIES

6. FINANCE
PRIVATEINVESTMENTSINCATALANLIFESCIENCECOMPANIES
MAB* VENTURE CAPITAL
Source: BiotechGate. Biocat Directory
IN MILLION EUROS / *MAB: Spanish sub-market for smaller, growing companies
35
30
25
20
15
10
5
0
2013
25.6
3.6
2012
18
5
2008
12,4
12.4
2010
6.6
2009
5.6
2011
12.9
4.3

7. ANINTERNATIONALCOMPETITIVER&DSYSTEM
Source: Government of Catalonia
1 2 3
2 UNIVERSITIES
AMONG THE 200
BEST IN
THE WORLD
3 UNIVERSITIES
AMONG
THE 50 BEST
UNDER
50 YEARS
19TH
BEST STUDENT
CITY OF THE WORLD
BARCELONA1 UNIVERSITY AMONG
THE 60 TOP
UNIVERSITIES
IN THE WORLD IN
SCIENTIFIC
PRODUCTION
CRG
9TH
IN THE TOP 100 BEST
BIOMEDICAL CENTERS
IN THE WORLD
Scimago Report (SIR 2013)
ICIQ
1ST
WORLD INSTITUTION
IN CHEMISTRY
Max Plank Institute (2014)
ICFO
1ST
WORLD INSTITUTION
IN PHYSICS
Max Plank Institute (2013)
URAP (2014) ARWU AND QS (2014)
QS TOP-50 UNIVERSITIES
UNDER 50 YEARS (2014) QS BEST STUDENTS CITIES 2015

8. EUROPEANRESEARCHCOUNCILGRANTS(ERC)
PERMILLIONINHABITANTS(2007-2014)
Source: Government of Catalonia
SWITZERLAND*
ISRAEL*
NETHERLANDS
CATALONIA
SWEDEN
DENMARK
UNITED KINGDOM
FINLAND
BELGIUM
CYPRUS
AUSTRIA
IRELAND
FRANCE
NORWAY
GERMANY
EUROPEAN UNION
EUROPEAN RESEARCH AREA
SPAIN
ITALY
HUNGARY
PORTUGAL
SPAIN EXCLUDING CATALONIA
GREECE
COUNTRY ERCGRANTS
39.3
34.1
25.1
20.4
5.9
7.4
7.9
3.2
CATALONIASTANDS
IN2ND
POSITIONIN
THEEUROPEAN
UNIONINTERMSOF
ERCGRANTS
17.3
16.8
15.7
14.0
13.5
12.8
12.7
10.7
9.1
8.5
7.9
4.5
4.0
3.7
3.1
*NON-EU COUNTRIES

9. SUCESSSTORIESSUCESSSTORIES

10. SUBSECTOROFACTIVITYOFMEDTECHCOMPANIES
Source: Biocat Directory (December 2014)
EACH COMPANY MAY BE INCLUDED INTO MORE THAN ONE CATEGORY
REUSABLE INSTRUMENTS
NON-ACTIVE IMPLANTABLE DEVICES
ELECTRO MECHANICAL MEDICAL DEVICES
DENTAL DEVICES
SINGLE USE DEVICES
OPHTHALMIC AND OPTICAL DEVICES
IMAGING
ANESTHETIC AND RESPIRATORY DEVICES
HOSPITAL HARDWARE
BIOMATERIALS
IN VITRO DIAGNOSTICS DEVICES
DIAGNOSTIC AND THERAPEUTIC RADIATION DEVICES
TECHNICAL AIDS FOR DISABLED PERSONS
REGENERATIVE MEDICINE
WOUND CARE
DELIVERY DEVICES
OTHER
THERAPEUTICAREAS NUMBEROFCOMPANIES
23
16
16
13
11
11
11
9
6
6
5
5
3
3
2
2
COMPANIESWORKINGINMEDTECH:
16
64
45
DEVELOP R&D
FOR NEW MEDICAL
AND DIAGNOSTIC
DEVICES
WORK IN RELATED
AREAS LIKE
SOFTWARE,
ELECTRONICS,
INSTRUMENTATION
OR DISTRIBUTION
109

11. MAINTHERAPEUTICAREAS(BIOTECH&PHARMA)
Source: Biocat Directory (December 2014)
CENTRAL NERVOUS SYSTEM
ONCOLOGY
CARDIOVASCULAR DISEASES
INFECTIOUS DISEASES
DERMATOLOGY
IMMUNOLOGY AND HEMATOLOGY
RESPIRATORY
INFLAMMATORY DISEASES
ENDOCRINOLOGY
MENTAL DISORDERS
GENITOURINARY SYSTEM
OPHTHALMOLOGY
DIGESTIVE SYSTEM
OBSTETRICS & GYNECOLOGY
OTOLOGY
THERAPEUTICAREAS NUMBEROFCOMPANIES
27
22
19
18
17
14
14
14
13
11
9
7
7
2
1
EACH COMPANY MAY BE INCLUDED INTO MORE THAN ONE CATEGORY

12. BIOTECHCOMPANIESACTIVITIES
Source: Biocat Directory (December 2014)
THERAPIES & DIAGNOSTICS
R&D SERVICES
BIOTECH-OTHER*
ACTIVITIES NUMBEROFCOMPANIES
49
72
76
*EACH COMPANY MAY BE INCLUDED INTO MORE THAN ONE CATEGORY
BIOTECH-OTHER*
45%
35%
11%
11%
14%
8%
VETERINARY
FOOD & NUTRACEUTICALS
AGROBIO
COSMETICS
INDUSTRIAL BIOTECHNOLOGY
ENVIRONMENTAL

13. 65%OFCATALANBIOTECH,PHARMAANDMEDTECH
COMPANIESARETRADINGTHEIRPRODUCTSIN
INTERNATIONALMARKETS
Source: Biocat's Internationalization Survey, 2013
30%
25%
20%
15%
10%
5%
0%
France
Germany
United States
Italy
Portugal
United Kingdom
Japan
Mexico
Russian Federation
Brasil
Switzerland
Sweden
Belgium
China
India
Percentatgeofcompanies
Sales Collaborations Future entrance
INTERNATIONALMARKETS

14. Source: Biocat Directory (December 2014)
ENTREPRENEURSHIP
INITIATIVESSUCHAS
BIOEMPRENEDORXXI
PROGRAM
SUPPORTEDTHE
CREATIONOF61
COMPANIES(2007-2014)
68 SPIN-OFF
FROMUNIVERSITIES,
RESEARCHINSTITUTES
ANDHOSPITALS
25
15
22
27 27
32
28
35
20
26
36 36
38
28
18
0
40
30
20
10
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
ACLUSTERINEXPANSION
NEWCOMPANIESCREATED(2000-2014)

15. 87%OFBIOREGIONCOMPANIESARESMEs
BIGCOMPANIESAREMAINLYMULTINATIONALPHARMAS
BIGCOMPANIES
MEDIUM-SIZED
COMPANIES
SMALL
COMPANIES
MICRO
COMPANIES
13%
19%
20%
48% COMPANIES
SIZE
Source: Biocat Directory (December 2014)
Company
category
Balance
sheet totalEmployees
Medium-sized
Small
Micro
< 250
< 50
< 10
≤ € 50 m
≤ € 10 m
≤ € 2 m
≤ € 43 m
≤ € 10 m
≤ € 2 m
Turnover

16. ABUSINESSHUBWITHBALANCEDREPRESENTATION
OFALLFIELDSOFLIFESCIENCES
Source: Biocat Directory (December 2014) and SABI
197BIOTECH
THERAPEUTICSANDDIAGNOSTICS9%
R&DSERVICES14%
OTHERS13%
PHARMA
7%
MEDICAL
TECHNOLOGY11%
SUPPLIER&
ENGINEERING
22%
PROFESSIONAL
SERVICESAND
CONSULTING
20%
INVESTORS
4%
49
76
72
64
39
124
111
25
THERAPEUTICSANDDIAGNOSTICS9%
> €5.000M
2.5%GDPCATALONIA
€154.8MINR&D
3.564EMPLOYEES(2.493INR&D)
€11.500M6%GDPCATALONIA*
35.000EMPLOYEES
560COMPANIES

17. BARCELONABARCELONA
CATALONIA
WITHALONGINDUSTRIALTRADITION,CATALONIAHAS
ADENSEANDINNOVATIVEINDUSTRIALCOMMUNITY
•23%OFSPANISHINVESTMENT
INR&D
•20%OFGDP
•45%OFPHARMACEUTICALINDUSTRY
•6%OFSPANISHTERRITORY
•15%OFPOPULATION(7MINHABITANTS)

18. BIOREGION OF CATALONIA
www.biocat.cat
IMPACT
METRICS